Research location
Los Gatos
California, United States
Advertisement
Research activity in Los Gatos
California, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 88 trials and 88 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Los Gatos
88 linked trials · page 2 of 2Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal ImpairmentNCT00663260 · 2008-06-01 · 1 site observation
COMPLETED
Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 DiabeticsNCT00698230 · 2008-05-01 · 1 site observation
COMPLETED
Safety and Efficacy Study of a Triple Combination Therapy in Subjects With HypertensionNCT00649389 · 2008-05-01 · 1 site observation
COMPLETED
A Study In Patients With Neuropathic Pain From Diabetic Peripheral Neuropathy (DPN)NCT00643760 · 2008-03-01 · 1 site observation
COMPLETED
Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 DiabetesNCT00622284 · 2008-02-01 · 1 site observation
COMPLETED
Effects of Metformin Hydrochloride (HCl) in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus and the Effects of Colesevelam HCl on Lipids and Glucose on Pre-diabetic Patients.NCT00570739 · 2007-11-01 · 1 site observation
COMPLETED
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and ExerciseNCT00528372 · 2007-09-01 · 1 site observation
COMPLETED
Mitiglinide in Combination With Metformin vs. Metformin Alone in Patients With Type 2 Diabetes MellitusNCT00519142 · 2007-08-01 · 1 site observation
COMPLETED
A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.NCT00461006 · 2007-06-01 · 1 site observation
COMPLETED
A Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential HypertensionNCT00696384 · 2007-06-01 · 1 site observation
COMPLETED
Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential HypertensionNCT00696241 · 2007-06-01 · 1 site observation
COMPLETED
Effects of Colesevelam HCl, Rosiglitazone, Sitagliptin on Control of Blood Glucose and Lipids in Type 2 Diabetes Patients Whose Blood Glucose Isn't Completely Controlled With MetforminNCT00484419 · 2007-05-01 · 1 site observation
COMPLETED
Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes MellitusNCT00760344 · 2007-03-01 · 1 site observation
COMPLETED
A Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE)NCT00443443 · 2007-01-01 · 1 site observation
COMPLETED
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or NaproxenNCT00346216 · 2006-10-04 · 1 site observation
COMPLETED
Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes MellitusNCT00376181 · 2006-06-01 · 1 site observation
TERMINATED
Exubera vs Lispro in a Lantus-based Regimen for Improved Glycemic Control in Type 2 DiabetesNCT00348374 · 2006-06-01 · 1 site observation
COMPLETED
A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy AloneNCT00295633 · 2006-03-01 · 1 site observation
COMPLETED
A Trial of BMS-512148 in Patients With Type 2 Diabetes MellitusNCT00263276 · 2005-12-01 · 1 site observation
COMPLETED
The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)NCT00279201 · 2005-12-01 · 1 site observation
COMPLETED
A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 DiabetesNCT00240253 · 2005-10-01 · 1 site observation
COMPLETED
Study of Muraglitazar Versus Pioglitazone in Type 2 DiabetesNCT00106808 · 2005-08-01 · 1 site observation
COMPLETED
Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe HypertensionNCT00185133 · 2005-05-01 · 1 site observation
COMPLETED
Pregabalin vs Placebo in Treatment of Neuropathic Pain Associated With Diabetic Peripheral NeuropathyNCT00143156 · 2005-03-01 · 1 site observation
COMPLETED
Long-Term Study of Safety and Efficacy of WelChol® as an Additional Therapy in Patients With Type 2 DiabetesNCT00151762 · 2004-12-01 · 1 site observation
COMPLETED
Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 DiabetesNCT00141492 · 2004-10-01 · 1 site observation
COMPLETED
WelChol® With Metformin in Treating Patients With Type 2 DiabetesNCT00147719 · 2004-06-01 · 1 site observation
COMPLETED
WelChol® and Sulfonylurea in Treating Patients With Type 2 DiabetesNCT00147758 · 2004-06-01 · 1 site observation
COMPLETED
PPAR - Combination With MetforminNCT00162240 · 2003-06-01 · 1 site observation
COMPLETED
A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic ControlNCT00246987 · 2003-06-01 · 1 site observation
COMPLETED
Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes MellitusNCT00108004 · 2003-04-01 · 1 site observation
COMPLETED
Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 DiabetesNCT00111540 · 2002-11-01 · 1 site observation
COMPLETED
Extension Study for 2993-112NCT01789957 · 2002-09-01 · 1 site observation
COMPLETED
Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes MellitusNCT00044694 · 2002-08-01 · 1 site observation
COMPLETED
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes MellitusNCT00035984 · 2002-05-01 · 1 site observation
COMPLETED
Dose Ranging Study With LT, Monotherapy, PPARNCT00240383 · 2002-05-01 · 1 site observation
COMPLETED
Iressa Expanded Access Program (EAP)NCT00034879 · 2000-08-01 · 1 site observation
COMPLETED
Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic PainNCT00082316 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.